title: Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2.
authors.forename: Franz X
authors.initials: FX
authors.lastname: Schaub
authors.forename: Thomas
authors.initials: T
authors.lastname: Lehmann
authors.forename: Renate
authors.initials: R
authors.lastname: Looser
authors.forename: Hui
authors.initials: H
authors.lastname: Hao-Shen
authors.forename: Andre
authors.initials: A
authors.lastname: Tichelli
authors.forename: Radek C
authors.initials: RC
authors.lastname: Skoda
mesh_terms: D004268:DNA-Binding Proteins / Q000172:deficiency / Q000235:genetics*; D049308:Dioxygenases; D019337:Hematologic Neoplasms / Q000235:genetics* / Q000473:pathology; D006412:Hematopoietic Stem Cells / Q000378:metabolism* / Q000473:pathology; D006720:Homozygote; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation; D011518:Proto-Oncogene Proteins / Q000172:deficiency / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D049308:Dioxygenases; C541081:TET2 protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2